Skip to main content

Table 4 Estimated population parameters for tazobactam using a modeling approach

From: Influence of extracorporeal membrane oxygenation on the pharmacokinetics of ceftolozane/tazobactam: an ex vivo and in vivo study

Parameter

Model mean

RSE (%)

Fixed effects

 Cl (l/h)

24.2

7.86

 βECMO/Cl

− 0.304

35.2

 V1 (l)

8.71

16.6

 Q (l/h)

7.19

26.4

 V2 (l)

6.37

14.1

BSV (%)

 Cl

11.3

44.9

 V1

32.4

38.7

 Q

31.9

44.5

 V2

15.1

44.5

 Residual variability (%)

19.9

10.8

  1. BSV between-subject variability, expressed as the coefficient of variation of the associated non-log-transformed parameter, RSE relative standard error